Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS)

NCT03800524 is registered in ClinicalTrials.gov with Humanitas Mirasole SpA as lead sponsor.

NCT NCT03800524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03800524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS)
Lead sponsor
Humanitas Mirasole SpA
Phase
Phase 3
Overall status
Unknown status
Start date
February 22, 2019
Completion date
December 31, 2023
Enrollment
337 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis (als)